WELLINGTON, Fla., Feb. 19, 2008 (PRIME NEWSWIRE) -- Ken Weiner, publisher of Shazamstocks.com, today announced profile coverage of NextGen Bioscience, Inc. ("NextGen") (OTCBB:NXGB). The Profile is a comprehensive look at the company's growth initiative. You can view the complete profile at http://www.shazamstocks.com/profiles/nxgb/index.php.
About NextGen Bioscience Inc.
NextGen is positioning itself as the world's leading bioscience company in the development and commercial licensure of novel therapeutic proteins that disrupt the advance of life-threatening cancers. The company leverages cutting-edge research collaborations to achieve breakthroughs in anti-cancer treatments, and then licenses these patented drug product candidates to Big Pharmaceutical and Biotechnology companies.
At present, NextGen is rapidly building its portfolio of proprietary biotechnology. Its first two anti-tumor drug candidates, Prostaganin (prostate cancer) and Tetanolic (breast cancer) -- both have incredible market potential as they may ultimately eliminate the need for surgery and chemotherapy and possess no side effects. NextGen's target market -- cancer treatments -- is the largest disease market, exploding at a 20% growth rate each year. NextGen's treatment niche is based on recent discoveries that indicate that most tumors are derived from a single cancer-initiating cell population which has stem cell properties (a cancer stem cell). NextGen has chosen to concentrate on identification of certain cell-specific characteristics, making it possible to identify precursor cells of tumors, and then conduct a more extensive 'fingerprinting' profile that will enable the development of cell-specific anti-cancer treatments. This will result in a 'tailor made' cancer treatment strategy that is superior to existing therapies in its ability to eradicate malignant cells whilst leaving healthy tissue intact.
About Shazamstocks.com
Shazamstocks.com is a Shazamstocks Inc. Company. Shazamstocks.com is a leading investor relations firm whose primary focus is promoting awareness among brokers, investors, and others in the investment community who are interested in small and micro-cap companies. Shazamstocks Inc. is dedicated to helping publicly traded companies gain the exposure they need to move forward with the development of their business plans. Shazamstocks.com's goal is to feature equity investments in micro or small capitalization companies that have the potential for long-term appreciation. Shazamstocks.com provides all investors with the latest news, press releases, investment opinions, and research reports for all the companies highlighted on the site. Stock alert offers a free financial newsletter. To subscribe or get more information, visit our home page located at http://www.shazamstocks.com. We offer many investor relations programs to public companies. To feature a company on our web site or in our daily Newsletter or Mid-Day Stock Alert, please contact Ken Weiner at 561-793-2665, or via email at editor@shazamstocks.com
Disclosure: We have been compensated by a third party, ONYX Consulting, twenty two thousand free trading shares of NXGB.
Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This release contains forward-looking information. Statements that are not descriptions of historical facts are forward-looking statements provided under the "safe harbor" protection of the Private Securities Litigation Reform Act of 1995. These statements are made to enable a better understanding of our business, but because these forward-looking statements are subject to many risks, uncertainties, future developments and changes over time, actual results may differ materially from those expressed or implied by such forward-looking statements. Examples of forward-looking statements are statements about anticipated financial or operating results, financial projections, business prospects, future product performance and other matters that are not historical facts. Such statements often include words such as "believes," "expects," "anticipates," "intends," "plans," "estimates" or similar expressions.
These forward-looking statements are based on the information that was currently available to us, and the expectations and assumptions that were deemed reasonable by us, at the time the statements were made. We do not undertake any obligation to update any forward-looking statements in this report or in any of our other communications, except as required by law, and all such forward-looking statements should be read as of the time the statements were made, and with the recognition that these forward-looking statements may not be complete or accurate at a later date.